Dave, Chris makes a valid point, which was strongl
Post# of 30028
Posted On: 11/18/2014 9:59:54 AM
Re: Daveludlow #11187
Dave, Chris makes a valid point, which was strongly supported by Gerald's statements and slides during the call.
I am less concerned after the call about the LymPro revenue discrepancy. It's going to be a non-issue for shareholders based on what was revealed in the call. LymPro will be either sold or spun off in the diagnostics division spin-off in 2015. It's in the presentation.
I am less concerned after the call about the LymPro revenue discrepancy. It's going to be a non-issue for shareholders based on what was revealed in the call. LymPro will be either sold or spun off in the diagnostics division spin-off in 2015. It's in the presentation.
(0)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼